Clinical Trial Update: Diacerein in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease [NA]

View source ↗

Summary

Clinical trial update on diacerein for metabolic dysfunction-associated fatty liver disease (MAFLD) noting the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Fatty Liver Disease

Drugs mentioned

• Diacerein (Diacerein)

Snippet

Sponsor: Hongyan Wu | Conditions: MAFLD | NA | Status: NOT_YET_RECRUITING